FDA Inspection 1014319 — Arizona Center for Reproductive Endocrinology & Infertility

Arizona Center for Reproductive Endocrinology & Infertility — FEI 3005391124

The FDA completed an inspection of Arizona Center for Reproductive Endocrinology & Infertility on March 22, 2017 in Tucson, AZ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 22, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Tucson, AZ (United States)